By Uduak Grace Thomas

Despite the complexities associated with semantic technologies, efforts to adopt the approach for drug development are bearing fruit, according to several presentations at last week's Conference on Semantics in Healthcare and Life Sciences in Cambridge, Mass.

In a conversation with BioInform, Ted Slater, head of knowledge management services at Merck and the CSHALS conference chair, described this year's meeting as "the strongest program" in the four years of its existence.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.